Vasculoprotective Effects of Anti-Tumor Necrosis Factor-α Treatment in Aging
- 1 January 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (1) , 388-398
- https://doi.org/10.2353/ajpath.2007.060708
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: role of NF-κB inhibitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Infliximab Improves Endothelial Dysfunction in Systemic VasculitisCirculation, 2004
- Targeted Anticytokine Therapy in Patients With Chronic Heart FailureCirculation, 2004
- Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Tumor Necrosis Factor Antagonism With Etanercept Improves Systemic Endothelial Vasoreactivity in Patients With Advanced Heart FailureCirculation, 2001
- Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart FailureCirculation, 2001
- Superoxide Excess in Hypertension and AgingHypertension, 2001
- Enhanced Peroxynitrite Formation Is Associated with Vascular AgingThe Journal of Experimental Medicine, 2000
- Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosisClinical and Experimental Immunology, 2000
- Peripheral Vascular Endothelial Dysfunction and Apoptosis in Old MonkeysArteriosclerosis, Thrombosis, and Vascular Biology, 2000